Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Facilitators of and barriers to adopting a restrictive red blood cell transfusion practice: a population-based cross-sectional survey.

Soril LJJ, Noseworthy TW, Stelfox HT, Zygun DA, Clement FM.

CMAJ Open. 2019 Apr 23;7(2):E252-E257. doi: 10.9778/cmajo.20180209. Print 2019 Apr-Jun.

2.

A retrospective observational analysis of red blood cell transfusion practices in stable, non-bleeding adult patients admitted to nine medical-surgical intensive care units.

Soril LJJ, Noseworthy TW, Stelfox HT, Zygun DA, Clement FM.

J Intensive Care. 2019 Apr 4;7:19. doi: 10.1186/s40560-019-0375-3. eCollection 2019.

3.

Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.

Soril LJJ, Seixas BV, Mitton C, Bryan S, Clement FM.

BMC Health Serv Res. 2018 Aug 15;18(1):640. doi: 10.1186/s12913-018-3459-1.

4.

Behaviour modification interventions to optimise red blood cell transfusion practices: a systematic review and meta-analysis.

Soril LJJ, Noseworthy TW, Dowsett LE, Memedovich K, Holitzki HM, Lorenzetti DL, Stelfox HT, Zygun DA, Clement FM.

BMJ Open. 2018 May 18;8(5):e019912. doi: 10.1136/bmjopen-2017-019912.

5.

UNTANGLING, UNBUNDLING, AND MOVING FORWARD: FRAMING HEALTH TECHNOLOGY REASSESSMENT IN THE CHANGING CONCEPTUAL LANDSCAPE.

Soril LJJ, Niven DJ, Esmail R, Noseworthy TW, Clement FM.

Int J Technol Assess Health Care. 2018 Jan;34(2):212-217. doi: 10.1017/S0266462318000120. Epub 2018 Apr 4.

PMID:
29616604
6.

Side Effects Associated with the Use of Intensity-Modulated Radiation Therapy in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: A Systematic Review and Meta-Analysis.

Jensen KE, Soril LJJ, Stelfox HT, Clement FM, Lin Y, Marshall DA.

J Med Imaging Radiat Sci. 2017 Dec;48(4):402-413. doi: 10.1016/j.jmir.2017.09.002. Epub 2017 Oct 18. Review.

PMID:
31047476
7.

Marijuana Use and Perceptions of Risk and Harm: A Survey among Canadians in 2016.

Spackman E, Haines-Saah R, Danthurebandara VM, Dowsett LE, Noseworthy T, Clement FM.

Healthc Policy. 2017 Aug;13(1):17-27.

8.

Achieving optimal technology use: A proposed model for health technology reassessment.

Soril LJ, MacKean G, Noseworthy TW, Leggett LE, Clement FM.

SAGE Open Med. 2017 Apr 19;5:2050312117704861. doi: 10.1177/2050312117704861. eCollection 2017.

9.

Screening for Obstructive Sleep Apnea: Important to Find, but How Hard Should We Look?

Pendharkar SR, Clement FM.

JAMA Intern Med. 2017 Apr 1;177(4):463-464. doi: 10.1001/jamainternmed.2016.9538. No abstract available.

PMID:
28118428
10.

La bioéthique, la réévaluation des technologies de la santé et la gestion.

Soril LJ, Clement FM, Noseworthy TW.

Healthc Manage Forum. 2016 Nov;29(6):279-283. Review.

PMID:
27807221
11.

Bioethics, health technology reassessment, and management.

Soril LJ, Clement FM, Noseworthy TW.

Healthc Manage Forum. 2016 Nov;29(6):275-278. Epub 2016 Oct 15. Review.

PMID:
27744278
12.

Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.

James MT, Wilton SB, Clement FM, Ghali WA, Knudtson ML, Tan Z, Tonelli M, Hemmelgarn BR, Norris CM; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) and Alberta Kidney Disease Network (AKDN) Investigators.

J Am Heart Assoc. 2016 Jul 19;5(7). pii: e003642. doi: 10.1161/JAHA.116.003642.

13.

Characteristics of frequent users of the emergency department in the general adult population: A systematic review of international healthcare systems.

Soril LJ, Leggett LE, Lorenzetti DL, Noseworthy TW, Clement FM.

Health Policy. 2016 May;120(5):452-61. doi: 10.1016/j.healthpol.2016.02.006. Epub 2016 Feb 27. Review.

PMID:
26947060
14.

Stakeholder Engagement to Identify Priorities for Improving the Quality and Value of Critical Care.

Stelfox HT, Niven DJ, Clement FM, Bagshaw SM, Cook DJ, McKenzie E, Potestio ML, Doig CJ, O'Neill B, Zygun D; Critical Care Strategic Clinical Network, Alberta Health Services.

PLoS One. 2015 Oct 22;10(10):e0140141. doi: 10.1371/journal.pone.0140141. eCollection 2015.

15.

Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study.

Weaver CG, Clement FM, Campbell NR, James MT, Klarenbach SW, Hemmelgarn BR, Tonelli M, McBrien KA; Alberta Kidney Disease Network and the Interdisciplinary Chronic Disease Collaboration.

Hypertension. 2015 Sep;66(3):502-8. doi: 10.1161/HYPERTENSIONAHA.115.05702. Epub 2015 Jul 13.

PMID:
26169049
16.

Reducing frequent visits to the emergency department: a systematic review of interventions.

Soril LJ, Leggett LE, Lorenzetti DL, Noseworthy TW, Clement FM.

PLoS One. 2015 Apr 13;10(4):e0123660. doi: 10.1371/journal.pone.0123660. eCollection 2015. Review.

17.

Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.

Leggett LE, Soril LJ, Coward S, Lorenzetti DL, MacKean G, Clement FM.

Prim Care Companion CNS Disord. 2015 Nov 5;17(6). doi: 10.4088/PCC.15r01807. eCollection 2015.

18.

Effective use of the built environment to manage behavioural and psychological symptoms of dementia: a systematic review.

Soril LJ, Leggett LE, Lorenzetti DL, Silvius J, Robertson D, Mansell L, Holroyd-Leduc J, Noseworthy TW, Clement FM.

PLoS One. 2014 Dec 17;9(12):e115425. doi: 10.1371/journal.pone.0115425. eCollection 2014. Review.

19.

Primary care physician visits by patients with incident hypertension.

Clement FM, Chen G, Khan N, Tu K, Campbell NR, Smith M, Quan H, Hemmelgarn BR, McAlister FA; Hypertension Outcome and Surveillance Team.

Can J Cardiol. 2014 Jun;30(6):653-60. doi: 10.1016/j.cjca.2014.03.033. Epub 2014 Mar 31.

20.

When is carotid angioplasty and stenting the cost-effective alternative for revascularization of symptomatic carotid stenosis? A Canadian health system perspective.

Almekhlafi MA, Hill MD, Wiebe S, Goyal M, Yavin D, Wong JH, Clement FM.

AJNR Am J Neuroradiol. 2014 Feb;35(2):327-32. doi: 10.3174/ajnr.A3682. Epub 2013 Aug 8.

21.

Malignant emboli on transcranial Doppler during carotid stenting predict postprocedure diffusion-weighted imaging lesions.

Almekhlafi MA, Demchuk AM, Mishra S, Bal S, Menon BK, Wiebe S, Clement FM, Wong JH, Hill MD, Goyal M.

Stroke. 2013 May;44(5):1317-22. doi: 10.1161/STROKEAHA.111.000659. Epub 2013 Mar 26.

PMID:
23532010
22.

Health technology reassessment of non-drug technologies: current practices.

Leggett L, Noseworthy TW, Zarrabi M, Lorenzetti D, Sutherland LR, Clement FM.

Int J Technol Assess Health Care. 2012 Jul;28(3):220-7. doi: 10.1017/S0266462312000438. Review.

PMID:
22980697
23.

Economic evaluation of increasing population rates of cardiac catheterization.

Clement FM, Ghali WA, Rinfret S, Manns BJ; APPROACH Investigators.

BMC Health Serv Res. 2011 Nov 24;11:324. doi: 10.1186/1472-6963-11-324.

24.

A multi-region assessment of population rates of cardiac catheterization and yield of high-risk coronary artery disease.

Clement FM, Manns BJ, Brownell B, Faris PD, Graham MM, Humphries K, Love M, Knudtson ML, Ghali WA; APPROACH Investigators.

BMC Health Serv Res. 2011 Nov 24;11:323. doi: 10.1186/1472-6963-11-323.

25.

Validating a case definition for chronic kidney disease using administrative data.

Ronksley PE, Tonelli M, Quan H, Manns BJ, James MT, Clement FM, Samuel S, Quinn RR, Ravani P, Brar SS, Hemmelgarn BR; Alberta Kidney Disease Network.

Nephrol Dial Transplant. 2012 May;27(5):1826-31. doi: 10.1093/ndt/gfr598. Epub 2011 Oct 19.

PMID:
22015442
26.

Nocturnal hypoxia and loss of kidney function.

Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, Klarenbach SW, Chin R, Clement FM, Hanly PJ.

PLoS One. 2011 Apr 29;6(4):e19029. doi: 10.1371/journal.pone.0019029.

27.

Validation of a case definition to define chronic dialysis using outpatient administrative data.

Clement FM, James MT, Chin R, Klarenbach SW, Manns BJ, Quinn RR, Ravani P, Tonelli M, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Med Res Methodol. 2011 Mar 1;11:25. doi: 10.1186/1471-2288-11-25.

28.

An economic evaluation of erythropoiesis-stimulating agents in CKD.

Clement FM, Klarenbach S, Tonelli M, Wiebe N, Hemmelgarn B, Manns BJ.

Am J Kidney Dis. 2010 Dec;56(6):1050-61. doi: 10.1053/j.ajkd.2010.07.015. Epub 2010 Oct 8.

PMID:
20932621
29.

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ.

JAMA. 2009 Oct 7;302(13):1437-43. doi: 10.1001/jama.2009.1409.

PMID:
19809025
30.

Economic evaluation of continuous renal replacement therapy in acute renal failure.

Klarenbach S, Manns B, Pannu N, Clement FM, Wiebe N, Tonelli M; Alberta Kidney Disease Network.

Int J Technol Assess Health Care. 2009 Jul;25(3):331-8. doi: 10.1017/S0266462309990134.

PMID:
19619352
31.

The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis.

Clement FM, Klarenbach S, Tonelli M, Johnson JA, Manns BJ.

Arch Intern Med. 2009 Jun 22;169(12):1104-12. doi: 10.1001/archinternmed.2009.112. Review.

PMID:
19546410
32.

Long-term outcomes of patients receiving drug-eluting stents.

Philpott AC, Southern DA, Clement FM, Galbraith PD, Traboulsi M, Knudtson ML, Ghali WA; APPROACH Investigators.

CMAJ. 2009 Jan 20;180(2):167-74. doi: 10.1503/cmaj.080050. Epub 2008 Dec 18.

Supplemental Content

Loading ...
Support Center